Charline Kieffer

414 total citations
18 papers, 301 citations indexed

About

Charline Kieffer is a scholar working on Molecular Biology, Organic Chemistry and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Charline Kieffer has authored 18 papers receiving a total of 301 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 9 papers in Organic Chemistry and 4 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Charline Kieffer's work include Protein Degradation and Inhibitors (5 papers), Ubiquitin and proteasome pathways (4 papers) and Quinazolinone synthesis and applications (3 papers). Charline Kieffer is often cited by papers focused on Protein Degradation and Inhibitors (5 papers), Ubiquitin and proteasome pathways (4 papers) and Quinazolinone synthesis and applications (3 papers). Charline Kieffer collaborates with scholars based in France, Australia and United States. Charline Kieffer's co-authors include Anne Sophie Voisin‐Chiret, Pierre Verhaeghe, Patrice Vanelle, Nicolas Primas, Pascal Rathelot, Nadine Azas, Sébastien Hutter, Sylvain Rault, Thomas Lemaître and Arvind Negi and has published in prestigious journals such as Journal of Medicinal Chemistry, Tetrahedron and Molecules.

In The Last Decade

Charline Kieffer

17 papers receiving 295 citations

Peers

Countries citing papers authored by Charline Kieffer

Since Specialization

Citations

This map shows the geographic impact of Charline Kieffer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charline Kieffer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charline Kieffer more than expected).

Fields of papers citing papers by Charline Kieffer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charline Kieffer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charline Kieffer. The network helps show where Charline Kieffer may publish in the future.

Co-authorship network of co-authors of Charline Kieffer

This figure shows the co-authorship network connecting the top 25 collaborators of Charline Kieffer. A scholar is included among the top collaborators of Charline Kieffer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charline Kieffer. Charline Kieffer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work	Indexed citations
1	PROTAC 2.0: Expanding the frontiers of targeted protein degradation 2025 ·Drug Discovery Today ·Marie Cornu, Thomas Lemaître, Charline Kieffer, Anne Sophie Voisin‐Chiret	15
2	UBE2N: Hope on the Cancer Front, How to Inhibit This Promising Target Prospect? 2025 ·Journal of Medicinal Chemistry ·(unknown), (unknown), (unknown), Shafi Ullah Khan, Jana Sopková‐de Oliveira Santos, Louis‐Bastien Weiswald, Anne Sophie Voisin‐Chiret, Matthieu Meryet‐Figuière, Charline Kieffer	1
3	Target fishing reveals PfPYK-1 and PfRab6 as potential targets of an antiplasmodial 4-anilino-2-trichloromethylquinazoline hit compound 2024 ·Bioorganic & Medicinal Chemistry ·Charline Kieffer, Nicolas Primas, Sébastien Hutter, Anaïs Merckx, Luc Reininger, Stéphane Bach, Sandrine Ruchaud, Fanny Gaillard, M. Laget, (unknown), (unknown), (unknown), (unknown), Aurélien Dumètre, S. Rault, Christian Doerig, Pascal Rathelot, Patrice Vanelle, Nadine Azas, Pierre Verhaeghe	0
4	Molecular glue degraders: exciting opportunities for novel drug discovery 2024 ·Expert Opinion on Drug Discovery ·Thomas Lemaître, (unknown), (unknown), Marc Since, Charline Kieffer, Anne Sophie Voisin‐Chiret	19
5	Computational Tool to Design Small Synthetic Inhibitors Selective for XIAP-BIR3 Domain 2023 ·Molecules ·(unknown), Charline Kieffer, (unknown), Anne Sophie Voisin‐Chiret, Jana Sopková‐de Oliveira Santos	3
6	Azobenzene Photoswitches in Proteolysis Targeting Chimeras: Photochemical Control Strategies and Therapeutic Benefits 2022 ·ChemistrySelect ·Arvind Negi, Charline Kieffer, Anne Sophie Voisin‐Chiret	15
7	PROTAC technology: A new drug design for chemical biology with many challenges in drug discovery 2022 ·Drug Discovery Today ·(unknown), (unknown), (unknown), Charline Kieffer, Anne Sophie Voisin‐Chiret	82
8	Noncellular screening for the discovery of protein–protein interaction modulators 2020 ·Drug Discovery Today ·Charline Kieffer, Jean‐Pierre Jourdan, Marie Jouanne, Anne Sophie Voisin‐Chiret	10
9	Sequential one pot double C H heteroarylation of thiophene using bromopyridines to synthesize unsymmetrical 2,5-bipyridylthiophenes 2017 ·Tetrahedron ·Charline Kieffer, (unknown), Marie Jouanne, (unknown), (unknown), Rémi Legay, Jana Sopková‐de Oliveira Santos, Sylvain Rault, Anne Sophie Voisin‐Chiret	4
10	Discovery of new hit-molecules targeting Plasmodium falciparum through a global SAR study of the 4-substituted-2-trichloromethylquinazoline antiplasmodial scaffold 2016 ·European Journal of Medicinal Chemistry ·Justine Desroches, Charline Kieffer, Nicolas Primas, Sébastien Hutter, Armand Gellis, Hussein El‐Kashef, Pascal Rathelot, Pierre Verhaeghe, Nadine Azas, Patrice Vanelle	27
11	Looking for new antileishmanial derivatives in 8-nitroquinolin-2(1H)-one series 2015 ·European Journal of Medicinal Chemistry ·Charline Kieffer, Anita Cohen, Pierre Verhaeghe, Sébastien Hutter, Caroline Castera‐Ducros, Michèle Laget, (unknown), (unknown), Sylvain Rault, Pascal Rathelot, Nadine Azas, (unknown)	12
12	Antileishmanial pharmacomodulation in 8-nitroquinolin-2(1H)-one series 2015 ·Bioorganic & Medicinal Chemistry ·Charline Kieffer, Anita Cohen, Pierre Verhaeghe, Lucie Paloque, Sébastien Hutter, Caroline Castera‐Ducros, Michèle Laget, Sylvain Rault, Alexis Valentin, Pascal Rathelot, Nadine Azas, Patrice Vanelle	8
13	Preventing the contamination of hospital personnel by cytotoxic agents: evaluation and training of the para-professional healthcare workers in oncology units 2014 ·European Journal of Cancer Care ·Charline Kieffer, Pierre Verhaeghe, (unknown), (unknown), (unknown), (unknown), (unknown), Patrice Vanelle, Pascal Rathelot	9
14	Synthesis and in vitro evaluation of 4-trichloromethylpyrrolo[1,2-a]quinoxalines as new antiplasmodial agents 2014 ·European Journal of Medicinal Chemistry ·Nicolas Primas, (unknown), Pierre Verhaeghe, Sébastien Hutter, Charline Kieffer, Michèle Laget, Anita Cohen, Julie Broggi, Jean‐Charles Lancelot, Aurélien Lesnard, Patrick Dallemagne, Pascal Rathelot, Sylvain Rault, Patrice Vanelle, Nadine Azas	36
15	A new DMAP-catalyzed and microwave-assisted approach for introducing heteroarylamino substituents at position-4 of the quinazoline ring 2014 ·Tetrahedron ·Armand Gellis, Charline Kieffer, Nicolas Primas, (unknown), Michel Giorgi, Pierre Verhaeghe, Patrice Vanelle	18
16	Characterisation of a Commercial Automotive NH3-SCR Copper–Zeolite Catalyst 2013 ·Topics in Catalysis ·Charline Kieffer, (unknown), (unknown), Nicolas Bats, Gérard Delahay	8
17	Sonogashira cross-coupling reaction in 4-chloro-2-trichloromethylquinazoline series is possible despite a side dimerization reaction 2013 ·Tetrahedron ·Charline Kieffer, Pierre Verhaeghe, Nicolas Primas, Caroline Castera‐Ducros, (unknown), Roselyne Rosas, Sylvain Rault, Pascal Rathelot, Patrice Vanelle	21
18	A New Synthetic Route to Original Sulfonamide Derivatives in 2-Trichloromethylquinazoline Series: A Structure-Activity Relationship Study of Antiplasmodial Activity 2012 ·Molecules ·Nicolas Primas, Pierre Verhaeghe, Anita Cohen, Charline Kieffer, Aurélien Dumètre, Sébastien Hutter, Sylvain Rault, Pascal Rathelot, Nadine Azas, Patrice Vanelle	13

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact